Publication | Closed Access
Discovery of a first-in-class orally available HBV cccDNA inhibitor
54
Citations
26
References
2022
Year
MedicineAntiviral Drug DevelopmentAntiviral TherapyVirologyAntiviral DrugPharmacologyDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1